TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19122076

Group type: EXPERIMENTAL
Intervention: Continuous lumbar plexus block with patient-controlled analgesia
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: Continuous femoral block with patient-controlled analgesia
Number of subjects: 225

Group type: COMPARATOR
Intervention: Patient-controlled analgesia alone
Number of subjects: 225
Study: 17599881

Group type: EXPERIMENTAL
Intervention: Innovative reperfusion technique (group II); pressure of 20 to 25 mmHg for 2 minutes, then increased to 40 mmHg for another 2 minutes.
Number of subjects: 57

Group type: COMPARATOR
Intervention: Standard techniques (group I); no specific intervention details provided.
Number of subjects: 57
Study: 14691442

Group type: EXPERIMENTAL
Intervention: Gradual and prolonged balloon angioplasty (GPBA)
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Cutting balloon angioplasty (CBA)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Conventional balloon angioplasty (POBA)
Number of subjects: 263
Study: 11944007

Group type: COMPARATOR
Intervention: Saline (Sal)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Gelofusine (Gel)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Levovist (Lev)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Gel vs Sal
Number of subjects: 25
Study: 9805323

Group type: EXPERIMENTAL
Intervention: Verbal span tasks
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Recency effect with visually and auditory presented lists
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Memory span tasks
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Recency and span measures
Number of subjects: 2
Study: 7695302

Group type: EXPERIMENTAL
Intervention: Mupirocin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral co-trimoxazole plus topical fusidic acid
Number of subjects: 0
Study: 2636671

Group type: EXPERIMENTAL
Intervention: New essential amino acid formulation (BS695), enriched with valine and threonine, low in phenylalanine and methionine, 3.65 g of nitrogen, i.v. three times per week for six months.
Number of subjects: 21

Group type: COMPARATOR
Intervention: Standard amino acid solution (control group), 3.65 g of nitrogen, i.v. three times per week for six months.
Number of subjects: 21
Study: 336670

Group type: EXPERIMENTAL
Intervention: Cyclandelate (1,600 mg/day in fractional doses)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo (identical-appearing capsules)
Number of subjects: 58
Study: 30788692

Group type: EXPERIMENTAL
Intervention: Mobile app-based small-group intervention
Number of subjects: 91

Group type: COMPARATOR
Intervention: Individual control condition
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Both groups (small-group and control)
Number of subjects: 91
Study: 28448174

Group type: EXPERIMENTAL
Intervention: Social marketing intervention (peer-led strategy)
Number of subjects: 393

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 393
Study: 24978063

Group type: EXPERIMENTAL
Intervention: I-gel
Number of subjects: 264

Group type: COMPARATOR
Intervention: LMA-supreme
Number of subjects: 264
Study: 25108576

Group type: EXPERIMENTAL
Intervention: Fish oil supplementation (4 capsules daily, 1.01 g EPA + 0.67 g DHA)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Corn oil (placebo)
Number of subjects: 108
Study: 22189085

Group type: EXPERIMENTAL
Intervention: High-oxygen modified atmosphere packaging (HiOx-MAP)
Number of subjects: 36

Group type: COMPARATOR
Intervention: PVC-overwrapping
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Old season (OS) lambs
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: New season (NS) lambs
Number of subjects: 36
Study: 19295240

Group type: EXPERIMENTAL
Intervention: Enzymatically modified isoquercitrin (EMIQ) 100 mg, two capsules daily for 8 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 18080048

Group type: EXPERIMENTAL
Intervention: Real rTMS (10 Hz, 100% resting motor threshold, 2 s on, 60 s off, 300 pulses total)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham TMS
Number of subjects: 20
Study: 15208005

Group type: EXPERIMENTAL
Intervention: Omega-3 Index > or = 8%
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Omega-3 Index < or = 4%
Number of subjects: 0
Study: 12043313

Group type: EXPERIMENTAL
Intervention: Chronic viral C hepatitis patients with steatosis
Number of subjects: 38

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Alcoholic liver steatosis
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Chronic viral C hepatitis patients without steatosis
Number of subjects: 38
Study: 10378358

Group type: EXPERIMENTAL
Intervention: H. pylori eradication therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7639006

Group type: EXPERIMENTAL
Intervention: Pylorus-preserving gastrectomy (PPG)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Conventional distal gastrectomy (CDG)
Number of subjects: 35
Study: 2487550

Group type: EXPERIMENTAL
Intervention: Ibopamine
Number of subjects: 103

Group type: COMPARATOR
Intervention: Hydrochlorothiazide/amiloride (diuretic therapy)
Number of subjects: 103
Study: 711931

Group type: EXPERIMENTAL
Intervention: Phenobarbital
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31508796

Group type: EXPERIMENTAL
Intervention: Monitored group (BIS monitoring)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care group (no BIS monitoring)
Number of subjects: 100
Study: 28556418

Group type: EXPERIMENTAL
Intervention: KHK4083 1.0 mg/kg SC
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: KHK4083 0.03, 0.1, 0.3, 1.0, 3.0, and 10 mg/kg IV
Number of subjects: 55

Group type: COMPARATOR
Intervention: KHK4083 (various doses)
Number of subjects: 55
Study: 25584800

Group type: EXPERIMENTAL
Intervention: Monochloroacetic acid (MCA) for common warts
Number of subjects: 415

Group type: COMPARATOR
Intervention: Cryotherapy for common warts
Number of subjects: 415

Group type: EXPERIMENTAL
Intervention: Monochloroacetic acid (MCA) for plantar warts
Number of subjects: 415

Group type: COMPARATOR
Intervention: Cryotherapy combined with salicylic acid (SA) for plantar warts
Number of subjects: 415
Study: 24908572

Group type: EXPERIMENTAL
Intervention: Narrow band imaging (Group 1)
Number of subjects: 237

Group type: COMPARATOR
Intervention: High definition white light colonoscopy (Group 2)
Number of subjects: 237
Study: 21720421

Group type: EXPERIMENTAL
Intervention: High GI/low protein
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: High GI/high protein
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Low GI/low protein
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Low GI/high protein
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 16
Study: 19726373

Group type: EXPERIMENTAL
Intervention: Amiodarone + Metoprolol
Number of subjects: 110

Group type: COMPARATOR
Intervention: Amiodarone
Number of subjects: 110

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 110
Study: 17200314

Group type: EXPERIMENTAL
Intervention: CHARITE Artificial Disc
Number of subjects: 276

Group type: COMPARATOR
Intervention: Control group (anterior interbody arthrodesis)
Number of subjects: 276
Study: 15543222

Group type: EXPERIMENTAL
Intervention: Insulin resistance
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 307
Study: 11524309

Group type: EXPERIMENTAL
Intervention: Lofexidine
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 9576302

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (low dose, < or =20 mg per day)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (low dose)
Number of subjects: 132
Study: 7955241

Group type: EXPERIMENTAL
Intervention: CABG in Group 1 (1970 to 1980)
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: CABG in Group 2 (1981 to 1991)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Group 1 (1970 to 1980)
Number of subjects: 201

Group type: COMPARATOR
Intervention: Group 2 (1981 to 1991)
Number of subjects: 201
Study: 2959438

Group type: EXPERIMENTAL
Intervention: metformin therapy
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: ultralente insulin
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: ultralente insulin alone
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: ultralente and soluble insulin
Number of subjects: 15
Study: 30526582

Group type: EXPERIMENTAL
Intervention: Papaya fortified porridge (300 ml daily)
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Albendazole (400 mg one-time dosage)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Plain porridge (control group)
Number of subjects: 326
Study: 27052694

Group type: EXPERIMENTAL
Intervention: Hark app
Number of subjects: 22

Group type: COMPARATOR
Intervention: Pager
Number of subjects: 22
Study: 25239451

Group type: EXPERIMENTAL
Intervention: Topical propolis
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 22508204

Group type: EXPERIMENTAL
Intervention: Vasopressin 0.03 IU/min for 60 min after cardiopulmonary bypass (CPB)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Normal saline in equal volume for 60 min after cardiopulmonary bypass (CPB)
Number of subjects: 20
Study: 19841932

Group type: EXPERIMENTAL
Intervention: Beta-alanine supplementation (4.8 g/day for 4 weeks)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 18390439

Group type: EXPERIMENTAL
Intervention: Calcium fumarate tablets
Number of subjects: 12

Group type: COMPARATOR
Intervention: Calcium gluconate tablets
Number of subjects: 12
Study: 16583594

Group type: EXPERIMENTAL
Intervention: meridol toothbrush
Number of subjects: 68

Group type: COMPARATOR
Intervention: standard ADA reference toothbrush
Number of subjects: 68
Study: 11811565

Group type: EXPERIMENTAL
Intervention: Raloxifene HCl (120 mg)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Raloxifene HCl (60 mg)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 9892858

Group type: COMPARATOR
Intervention: Fentanyl (0.2 microgram/kg body weight)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Low doses of alcohol (BAC 0.03%)
Number of subjects: 24
Study: 7735607

Group type: EXPERIMENTAL
Intervention: 77 ppb HONO
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 395 ppb HONO
Number of subjects: 15

Group type: COMPARATOR
Intervention: Clean air
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: HONO exposure
Number of subjects: 15
Study: 1447397

Group type: EXPERIMENTAL
Intervention: Type 1 diabetics (n=28)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Type 2 diabetics (n=172)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Overall diabetics (n=200)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (n=200)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Type 1 diabetics (n=28) vs Control group (n=200)
Number of subjects: 200
Study: 3514193

Group type: EXPERIMENTAL
Intervention: Biosynthetic growth hormone (methionyl-hGH) administered to group I (32 children) with high ECP content
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Biosynthetic growth hormone (methionyl-hGH) administered to group II (12 children) with reduced ECP content
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Biosynthetic growth hormone (methionyl-hGH) administered to group III (11 children) with almost ECP-free preparations
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: High antibody titres against ECP and hGH in group I
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: A boy with allergy in group I
Number of subjects: 55
Study: 29064599

Group type: EXPERIMENTAL
Intervention: Spinal Cord Stimulation (SCS)
Number of subjects: 0
Study: 27126621

Group type: EXPERIMENTAL
Intervention: Combined tri-endoscopic group (29 patients)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (24 patients)
Number of subjects: 53
Study: 26389639

Group type: EXPERIMENTAL
Intervention: Oral-methylphenidate
Number of subjects: 303

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 303
Study: 23219629

Group type: EXPERIMENTAL
Intervention: PhysioDirect telephone assessment and advice service
Number of subjects: 350000
Study: 21978241

Group type: EXPERIMENTAL
Intervention: Electromyostimulation superimposed over voluntary contraction (EVG)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 40
Study: 18452433

Group type: EXPERIMENTAL
Intervention: Asiaticoside-containing cream applied twice a day for 12 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Vehicle control cream applied to the other eye
Number of subjects: 27
Study: 16688996

Group type: EXPERIMENTAL
Intervention: Oxymatrine (Oxy)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Propafenone
Number of subjects: 110
Study: 12713209

Group type: EXPERIMENTAL
Intervention: 4-week summer day camp + 8-week home Internet intervention
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (different 4-week summer day camp + monthly home Internet intervention)
Number of subjects: 35
Study: 10636973

Group type: EXPERIMENTAL
Intervention: Dietary counseling aimed to reach a dietary fat ratio of unsaturated to saturated fat of 2:1 within a total fat intake of 30% to 35% of energy (E%)
Number of subjects: 813

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 813

Group type: EXPERIMENTAL
Intervention: Dietary counseling intervention
Number of subjects: 813

Group type: EXPERIMENTAL
Intervention: Dietary intervention replacing saturated with unsaturated fatty acids
Number of subjects: 813
Study: 7495976

Group type: EXPERIMENTAL
Intervention: Octavi S/D
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Octavi S/D+heat treatment
Number of subjects: 0
Study: 2317422

Group type: EXPERIMENTAL
Intervention: Single-holed catheter
Number of subjects: 474

Group type: COMPARATOR
Intervention: Multi-holed catheter
Number of subjects: 474
Study: 6244679

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with VM 26 and CCNU once every four weeks, commencing four weeks after the completion of radiotherapy.
Number of subjects: 31

Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 31
Study: 31732883

Group type: COMPARATOR
Intervention: Fluoride toothpaste (500 ppm, n=50)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: CPP-ACP (10% w/v, n=38)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Combination group (Fluoride then CPP-ACP, n=39)
Number of subjects: 127
Study: 30714336

Group type: EXPERIMENTAL
Intervention: Phaco-EX-PRESS P50 with mitomycin C (0.2 mg/ml for 2 min)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Phaco-NPDS with Esnoper V2000 and mitomycin C (0.2 mg/ml for 2 min)
Number of subjects: 98
Study: 28906355

Group type: EXPERIMENTAL
Intervention: TACE and sorafenib
Number of subjects: 72

Group type: COMPARATOR
Intervention: TACE alone
Number of subjects: 72
Study: 26003782

Group type: EXPERIMENTAL
Intervention: Aspirin and clopidogrel 75mg/d
Number of subjects: 52

Group type: COMPARATOR
Intervention: Aspirin monotherapy
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: ADP-induced aggregation <50%
Number of subjects: 52
Study: 23093541

Group type: EXPERIMENTAL
Intervention: 100 mg prednisone over 5 days
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo over 5 days
Number of subjects: 96
Study: 21641867

Group type: EXPERIMENTAL
Intervention: Continuous oxaliplatin and fluoropyrimidine combination chemotherapy (arm A)
Number of subjects: 1630

Group type: COMPARATOR
Intervention: Intermittent chemotherapy (arm C)
Number of subjects: 1630

Group type: EXPERIMENTAL
Intervention: Continuous chemotherapy (arm A)
Number of subjects: 1630
Study: 19564220

Group type: EXPERIMENTAL
Intervention: Assertive Community Treatment (ACT)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Usual Care from Community Mental Health Teams (CMHTs)
Number of subjects: 251
Study: 16254730

Group type: EXPERIMENTAL
Intervention: Stimulant therapy
Number of subjects: 13
Study: 14698365

Group type: EXPERIMENTAL
Intervention: Droperidol 10 microg/kg IV before skin incision (Group P)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Droperidol 10 microg/kg IV after skin incision (Group A)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 84
Study: 10996442

Group type: EXPERIMENTAL
Intervention: Haloperidol (2mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 9493662

Group type: EXPERIMENTAL
Intervention: Cathepsin G-like activities
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Tryptase-like activities
Number of subjects: 38

Group type: COMPARATOR
Intervention: Plasmin-like activities
Number of subjects: 38
Study: 8790615

Group type: EXPERIMENTAL
Intervention: Self-reported cataract diagnosis
Number of subjects: 22071
Study: 3594105

Group type: EXPERIMENTAL
Intervention: Papaverine and phentolamine (30 mg papaverine and 1 mg phentolamine, 2 ml injection)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Saline (2 ml injection)
Number of subjects: 18
Study: 31793041

Group type: EXPERIMENTAL
Intervention: MAL-photodynamic therapy (MAL-PDT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ingenol mebutate gel (IMB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: diclofenac plus hyaluronate gel (DHA)
Number of subjects: 0
Study: 29689257

Group type: EXPERIMENTAL
Intervention: Diphenhydramine (50 mg IV)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study: 28453584

Group type: EXPERIMENTAL
Intervention: Structured educative program
Number of subjects: 115

Group type: COMPARATOR
Intervention: No structured education (control)
Number of subjects: 115
Study: 24147575

Group type: EXPERIMENTAL
Intervention: Traditional protocol (T group)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Simplified protocol (S group)
Number of subjects: 50
Study: 23632672

Group type: EXPERIMENTAL
Intervention: Local infiltration analgesia with peri-articular injection of bupivacaine, morphine, and methylprednisolone.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Patient-controlled epidural analgesia (PCEA) plus femoral nerve blockade with bupivacaine nerve block and bupivacaine/hydromorphone PCEA.
Number of subjects: 90
Study: 21099647

Group type: EXPERIMENTAL
Intervention: Guided imagery intervention (listened to a guided imagery CD)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Control group (no guided imagery intervention)
Number of subjects: 121
Study: 19058099

Group type: EXPERIMENTAL
Intervention: Passive alcohol sensor (PAS)
Number of subjects: 714

Group type: COMPARATOR
Intervention: No passive alcohol sensor (Control group)
Number of subjects: 714
Study: 16621186

Group type: EXPERIMENTAL
Intervention: Avaxim
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Vaqta
Number of subjects: 120
Study: 12859221

Group type: EXPERIMENTAL
Intervention: Sequential high dose chemotherapy (HDC) with granulocyte colony-stimulating factor (filgrastim) and stem cell support
Number of subjects: 95

Group type: COMPARATOR
Intervention: Single course HDC with bone marrow transplantation (BMT)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Single course HDC with peripheral blood stem cell transplantation (PBSCT)
Number of subjects: 95
Study: 11212135

Group type: EXPERIMENTAL
Intervention: Neuropsychological counseling
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard, non-specific supportive psychotherapy
Number of subjects: 15
Study: 9001371

Group type: EXPERIMENTAL
Intervention: DHA supplementation (1.62 g/d)
Number of subjects: 24
Study: 1309944

Group type: EXPERIMENTAL
Intervention: Continuous estradiol valerate (2 mg) plus cyproterone acetate (1 mg)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Sequential estradiol valerate (2 mg) plus levonorgestrel (75 micrograms)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 6734703

Group type: EXPERIMENTAL
Intervention: Theolin Retard 300 mg (sustained release tablet)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intravenous aminophylline (reference material)
Number of subjects: 10
Study: 30955455

Group type: EXPERIMENTAL
Intervention: 3 mg.kg-1 caffeine (CAF3)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 6 mg.kg-1 caffeine (CAF6)
Number of subjects: 14

Group type: COMPARATOR
Intervention: No substance (Control - CON)
Number of subjects: 14
Study: 30328899

Group type: EXPERIMENTAL
Intervention: Ethanol (E)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-ethanol (N)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Etch-and-rinse (Er) with ethanol (E)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Self-etching (S) with non-ethanol (N)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Aged groups (A) with ethanol (E)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-aged groups (Na) with non-ethanol (N)
Number of subjects: 20
Study: 27293053

Group type: COMPARATOR
Intervention: Single intramuscular injection of bone marrow mononuclear cells (n = 11)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Four intramuscular injections of bone marrow mononuclear cells (n = 11)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both single and four injections of bone marrow mononuclear cells
Number of subjects: 22
Study: 24568487

Group type: EXPERIMENTAL
Intervention: Nedaplatin (NDP)
Number of subjects: 619

Group type: COMPARATOR
Intervention: Cisplatin (DDP)
Number of subjects: 619
Study: 22408783

Group type: EXPERIMENTAL
Intervention: Tescera ATL (TATL)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Aelite Aesthetic (AA)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Tetric EvoCeram (TEC)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Filtek Supreme XT (FS)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Estenia (E)
Number of subjects: 54
Study: 19576318

Group type: EXPERIMENTAL
Intervention: Eptifibatide plus a heparin product
Number of subjects: 857

Group type: COMPARATOR
Intervention: Bivalirudin monotherapy
Number of subjects: 857

Group type: EXPERIMENTAL
Intervention: Ischemia duration
Number of subjects: 857

Group type: EXPERIMENTAL
Intervention: Ischemic events within the first 4 hours after PCI
Number of subjects: 857